A ccumulation of lipids within the artery wall is a fundamental feature of atherosclerosis. 1 Within vascular cells, lipids accumulate as cytoplasmic droplets of cholesterol esters and triglycerides; cells with an abundance of these droplets are termed foam cells. Macrophages are considered the primary source of foam cells in atherosclerosis. 2 However, it has been established for many years that atherosclerotic lesions also contain abundant foam cells with a vascular smooth muscle cell (VSMC) identity. [3] [4] [5] Consistent with this, VSMCs in culture can accrue neutral lipids when challenged with hyperlipidemic serum or atherogenic lipoproteins. 6, 7 
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The fate of lipid-laden VSMCs is beginning to be understood, and it would be incorrect to assume that it is identical to that of macrophage foam cells. Incorporation of lipids by macrophages will result in cell death once the macrophage's capacity to esterify the otherwise toxic free cholesterol is exceeded. 8 Macrophage foam cells may also have relatively productive roles within lesions, including phagocytosis and efferocytosis of apoptotic cells, processes critical for limiting the dispersal of lipid and inflammatory products from dying cells. 9 In contrast, VSMCs are more resistant than macrophages to the toxicity of free cholesterol. 10 As well, their ability to acquire functional characteristics of macrophages is uncertain.
A vital role played by healthy VSMCs is to stabilize the vessel wall through the elaboration of fibrils of type I collagen. 11 Type I collagen is secreted from the cell as a soluble protein that must then polymerize into insoluble fibrils to confer mechanical properties. 12 Although healthy VSMCs orchestrate the brisk assembly of collagen fibrils from soluble precursors, 12 until recently it was not known whether VSMC-derived foam cells within lesions were capable of performing this role. This is important given that lesions with high lipid content are precisely those requiring stabilization by a fibrous collagen-rich cap. Frontini et al 13 discovered that uptake of atherogenic lipoproteins by human VSMCs inhibited Src-dependent assembly of fibronectin and type I collagen, suggesting a mechanism underlying plaque vulnerability. Subsequently, Beyea et al 14 reported that induction of cholesterol efflux by liver X receptor activation restored the ability of VSMC-derived foam cells to elaborate extracellular matrix, thus revealing a potential therapeutic target.
In previous studies, Rong et al 15 discovered that mouse aortic VSMCs that were loaded with cholesterol adopted macrophagelike characteristics, raising the possibility that foam cells within plaques, may be VSMC derived, rather than macrophages. After cholesterol loading, murine VSMCs showed a marked decline in the expression of genes related to a contractile phenotype smooth muscle alpha actin 2 (Acta2) and calponin h1 (Cnn1) and increased the expression of the macrophage marker CD68 cluster of differentiation 68 (Cd68). Using novel lineage tracing techniques, 2 laboratories recently reported macrophage-like cells of VSMC origin in murine and in human atherosclerotic plaques. 16, 17 These intriguing reports are consistent with recent studies of Allahverdian et al, 18 demonstrating that >40% of CD68-positive cells originated as VSMCs in advanced human coronary atherosclerosis. Collectively, these findings point to a phenomenon of plasticity. However, caution must be applied when interpreting cell phenotypes based on the expression of a selected number of genes or selected cell behaviors.
In this issue, Vengrenyuk et al 19 provide exciting new insights into gene expression patterns of VSMC-derived foam cells and into the functional behavior of these cells ( Figure) . Cultured VSMCs, primarily of mouse origin, were cholesterol loaded with cyclodextrin-cholesterol complexes and subjected to transcriptional profiling. Cholesterol loading upregulated macrophage markers Cd68 and galectin-3 and the cholesterol efflux transporters ATP binding cassettes A1 and G1, whereas the VSMC markers Cnn1, Actg2, and tropomyosin alpha 1 were suppressed. Cholesterol loading also upregulated several macrophage-specific inflammatory cytokine mRNAs, including Ccl2 and Ccl7, as well as the toll-like receptor 4, an initiator of proinflammatory responses. However, principle component analyses of their VSMC microarray data, together with published array data for macrophages, monocytes, and dendritic cells, revealed that profiles of cholesterol-loaded murine VSMCs remained distinguishable from those of hematopoietic cells. Furthermore, 2 signature genes of mature tissue macrophages, namely c-mer proto-oncogene tyrosine kinase and cluster of differentiation 64, were not upregulated in cholesterol-loaded VSMCs. Of significance, 2 key functional properties of cholesterol-loaded peritoneal macrophages, namely phagocytosis and efferocytosis of apoptotic cells, were highly deficient in cholesterolloaded VSMCs. In atherosclerotic plaques from apolipoprotein E-deficient mice, lipid-rich cells positive for both VSMC and macrophage markers were found lining the necrotic core.
In an effort to identify the underlying mechanisms for cholesterol-induced changes in VSMC gene expression, transcription factor binding analyses identified serum response factor (SRF) and its smooth muscle-specific transcriptional coactivator, myocardin (Myocd), as factors that were downregulated in parallel with Cnn1 in cholesterol-loaded VSMCs. Furthermore, overexpression of myocardin both prevented and reversed the decrease in ACTA2, Srf and Cnn1 and the increase in CD68. The expression of both microRNA (miR)-143 and miR-145, known regulators of myocardin expression and phenotypic switching of VSMCs, 20 were downregulated by cholesterol loading. Furthermore, miR-143/miR-145 mimics prevented the decreased expression of both Srf and Myocd and partially restored decreased Cnn1 mRNA levels in response to cholesterol loading of VSMCs. The addition of apoAI or high-density lipoprotein to induce cholesterol efflux, reversed cholesterol-induced changes in the expression of Acta2, Cd68, Cnn1, Myocd, and miR-143/miR-145, providing further evidence that changes in signaling through the miR-143/miR-145/ SRF/myocardin axis were responsible for the loss of contractile features and gain of macrophage markers in VSMCs exposed to cholesterol. In preliminary experiments, kruppellike factor 4 (Klf4), a known repressor of SRF/myocardin, and transforming growth factor β, a promoter of the contractile VSMC contractile phenotype, were also implicated in the cholesterol-induced loss of VSMC gene expression and increased expression of macrophage-like gene expression patterns. The authors concluded that although VSMC foam cells would be classified by immunohistochemistry as macrophages, analysis of their complete transcriptome together with their inability to acquire functional macrophage-like properties suggests that their contributions to atherogenesis or regression would not be akin to those of the classical macrophage-derived foam cell.
The novel observations in this article have many important implications. First, they confirm that cholesterol-loaded VSMCs lose some SMC characteristics and acquire several macrophage-like gene and protein expression patterns. Second, they point to a proinflammatory role for cholesterolloaded VSMCs based on the elaboration of inflammatory cytokines generally attributed macrophages. Third, they provide further evidence for the plasticity of VSMCs on exposure to cholesterol. 21 Fourth, they highlight the potential to misclassify these cells as being of macrophage origin, when using macrophage histological markers such as CD68. Fifth, the results support recent findings that human VSMC-derived 
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foam cells represent a significant proportion of lesional foam cells (>40%). 18 These cells not only make a significant contribution to plaque volume and necrotic core formation but also suppress plaque stability. Sixth, the authors identified the miR-143/miR-145/SRF/myocardin pathway as 1 mechanism underlying the transition of VSMCs exposed to cholesterol. Seventh, that cholesterol-loaded VSMCs fail to acquire key functional properties of macrophage foam cells, namely phagocytosis and efferocytosis. The authors have focused on macrophage-like features acquired by cholesterol-loaded VSMCs, with less emphasis on VSMC characteristics lost by these cells upon foam cell formation. Frontini et al 13 reported that lipid loading of human VSMCs by incubation with human atherogenic lipoproteins disables the machinery for type I collagen and fibronectin assembly. This has the potential to diminish the capacity of these cells to synthesize a fibrous cap and to greatly enhance plaque vulnerability. Consistent with these observations, the microarray analyses in the present study revealed that in cholesterol-loaded murine VSMCs, several genes involved in extracellular matrix elaboration, including type I collagen, were downregulated. If this were to occur in vivo, it would provide another strong rationale for the development of interventions for the suppression of VSMC foam cell formation.
The promotion of cholesterol efflux from cholesterol-loaded murine VSMCs reversed the expression patterns of ACTA2, CD68, Cnn1, Myocd, and miR-143/145, providing further evidence that the phenotypic change was a direct effect of exposure to cholesterol. However, the consequences of enhanced efflux on VSMC function were not explored. In this regard, however, recent in vitro studies in cholesterol-loaded human VSMCs demonstrated that induction of cholesterol efflux by liver X receptor agonists preserved the assembly of fibronectin and type I collagen fibers by VSMCs. 14 Thus, and as suggested by the authors of the present study, therapeutic approaches to stimulate efflux from VSMCs in vivo may promote fibrous cap formation and result in enhanced plaque stability.
Vengrenyuk et al 19 suggest that their results apply to human VSMCs and present a preliminary experiment in cholesterolloaded human coronary artery VSMCs showing decreased mRNA expression of ACTA2, transgelin, as well as modest suppression of miR-143 and -145 expression. This differs somewhat from a previous report demonstrating that lipidloaded human VSMCs exposed to human atherogenic lipoproteins did not change expression patterns of the VSMC proteins ACTA2, h-caldesmon or calponin h1. 13 Because the plasticity of murine cells may not reflect that of human cells, future studies are required in human VSMCs cells to fully establish the impact of cholesterol loading on the diverse array of experimental end points described for mouse VSMCs. Also, the murine VSMCs in the current report were cholesterol-loaded artificially via cyclodextrin, a mechanism not likely responsible for the majority VSMC-foam cells in vivo. Atherogenic lipoproteins are readily taken up by VSMCs in culture resulting in lipid loading and foam cell formation. It is possible that changes in gene expression and/or phenotypic characteristics of SMCs in response to physiological induction by atherogenic lipoproteins differs from those induced by cyclodextrin-cholesterol. Such studies should be performed prior to extrapolating the present results to human cells and the in vivo arena. Another intriguing question will be to identify the mechanism linking cholesterol uptake with activation of the miR-143/miR-145/SRF/myocardin pathway This report by Vengrenyuk et al, 19 thus provides valuable in-depth gene and protein expression analyses of cholesterolloaded murine VSMCs. Cholesterol loading imparts some macrophage-like features and suppresses some VSMC-like characteristics through downregulation of the miR-143/miR-145/SRF/myocardin axis. These cells might be classified by immunohistochemistry as macrophages using selected conventional markers, such as CD68. However, they are in fact only disguised as macrophage foam cells. Full transcriptome analysis reveals that they remain more like VSMCs, and they do not acquire the important macrophage functional characteristics of phagocytosis or efferocytosis. It would seem that although VSMC foam cells can attend the masquerade, like the leopard, they do not truly change their spots.
